1. Home
  2. AI vs ALVO Comparison

AI vs ALVO Comparison

Compare AI & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C3.ai Inc.

AI

C3.ai Inc.

HOLD

Current Price

$9.31

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.70

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AI
ALVO
Founded
2009
2013
Country
United States
Luxembourg
Employees
N/A
1460
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
AI
ALVO
Price
$9.31
$3.70
Analyst Decision
Hold
Buy
Analyst Count
14
4
Target Price
$14.00
$8.00
AVG Volume (30 Days)
8.0M
1.1M
Earning Date
05-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$250,268,000.00
N/A
Revenue This Year
N/A
$13.28
Revenue Next Year
N/A
$18.63
P/E Ratio
N/A
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$7.68
$2.94
52 Week High
$30.11
$9.94

Technical Indicators

Market Signals
Indicator
AI
ALVO
Relative Strength Index (RSI) 40.16 49.75
Support Level $8.01 $3.65
Resistance Level $9.79 $3.83
Average True Range (ATR) 0.72 0.32
MACD -0.21 -0.03
Stochastic Oscillator 3.41 39.24

Price Performance

Historical Comparison
AI
ALVO

About AI C3.ai Inc.

C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: